|
|
|
|
|
by AlbertCory
1782 days ago
|
|
as for Springer, Taylor & Francis, and Wiley-Blackwell: yeah, them too. Forgot to mention those. The paid journals take research which is mostly paid for with public or non-profit money, and hide it behind paywalls. You can't avoid this fact. Their "reputation" is mostly just a legacy, like the New York Times'. At one time they sent out paper journals, which was the only way information could be disseminated, and charged libraries reasonable fees. There was a manageable number of such journals so a library could get most or all of them. That world is gone. |
|
Commercial publishers have paywalls, but for new research they no longer have to be the only source for publications.
Nowadays, I think it’s often the indifference/laziness/whatever of the authors that prevent accepted manuscripts (same text, but different layout) from also being freely accessible.
For example https://www.elsevier.com/about/policies/sharing allows putting accepted manuscripts on arXiv.
The way I read it, the main limitations are:
- you can’t put your paper on a commercial site.
- you have to mention the DOI, which, I guess, resolves to Elsevier’s site.
Reading https://www.elsevier.com/about/policies/hosting (“Sites or repositories that provide a service to other organizations or agencies, even if those other organizations or agencies are themselves non-commercial entities, are considered to be providing a commercial service, and this service activity will also require a commercial arrangement with Elsevier”), they make special exceptions for arXiv and RePEc.
So, that’s not optimal, but (for new papers) also not as bleak as it typically is described.